查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肿瘤血液学分子检测市场与 COVID-19 影响分析，按产品类型、癌症类型、技术、最终用途、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1339883

肿瘤血液学分子检测市场与 COVID-19 影响分析，按产品类型、癌症类型、技术、最终用途、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Onco-hematology Molecular Testing Market with COVID-19 Impact Analysis, By Product Type, By Cancer Type, By Technology, By End-use, By Country, and By Region - Industry Analysis, Market Size,Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年，肿瘤血液学分子检测市场规模为5.308亿美元，2023年至2030年復合年增长率为13.3%。

肿瘤血液学分子检测市场-市场动态：

  • 癌症病例发病率的上升和分子诊断测试的新进展可能会推动市场需求。
  • 全球癌症病例的患病率不断上升，推动了诊断需求，这也推动了肿瘤血液学分子检测市场的发展。此外，癌症病例导致对早期检测和预防医学的需求不断增长。因此，这些因素稳步增加了肿瘤血液学分子检测市场的需求。此外，随着诊断测试最终用途的进步，肿瘤学分子诊断测试变得越来越流行。在癌症基因组测序、肿瘤模型、计算分析和创新的癌症研究方法中，正在进行大量的研究。然而，在癌症护理中，分子诊断测试的成本相对较高，并且根据治疗类型的不同而有所不同，预计这将限制预测期内的市场增长。

肿瘤血液学分子检测市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球肿瘤血液学分子检测市场在预测期内（2023-2030 年）每年将以 13.3% 左右的复合年增长率增长
  • 由于医疗保健基础设施数量的不断增加和完善的医疗保健基础设施，肿瘤血液学分子检测行业预计将以显着的速度增长
  • 基于技术细分，预计下一代测序将在 2022 年呈现最大市场份额
  • 从产品类型细分来看，2022年服务类型为主导
  • 按地区划分，亚太地区是 2022 年的主要收入来源

肿瘤血液学分子检测市场-細項分析：

  • 全球肿瘤血液学分子检测市场根据产品类型、癌症类型、技术、最终用途和地区进行细分。
  • 市场根据产品类型分为两类：服务和检测试剂盒和试剂。由于非霍奇金淋巴瘤、白血病和骨髓瘤的发病率不断增加，服务领域可能会在预测期内保持其主导地位。此外，该细分市场的增长是由于人们对包括个性化药物在内的多种治疗方法的认识不断提高而推动的。骨髓瘤诊断服务的不断增加归因于市场的增长。
  • 根据癌症类型，市场分为四类：肺癌、血液癌、乳腺癌、结直肠癌等。其他癌症领域的市场增长率最高。全球范围内胃癌、前列腺癌和胰腺癌等各种癌症患病率的上升推动了该细分市场的增长。
  • 市场根据技术分为三类：qPCR、dPCR、新一代测序和其他。下一代测序领域可能拥有最大的收入份额。该技术提供的众多优势，包括特异性和更高的灵敏度，预计将推动该细分市场的增长。此外，下一代测序测试用于检查诊断为淋巴细胞白血病的患者体内残留的低水平癌细胞。 FDA 批准基于 NGS 的测试归因于推动市场增长。
  • 根据最终用途，市场分为两类：参考实验室、医院和其他。医院部门预计将占据最大的收入份额。癌症患者就诊和诊断的人数不断增加可能会推动这一增长。此外，由于上述因素，血癌发病率的上升、进行诊断测试和监测疾病的医疗保健专业人员的存在以及专业实验室设施的可用性正在见证增长。

肿瘤血液学分子检测市场-地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

肿瘤血液学分子检测市场-竞争格局：

不断上涨的医疗保健成本和旨在改善癌症治疗和诊断的政府倡议正在推动市场收入增长。世界各国政府正在资助新的癌症诊断设备和治疗方案的开发。此外，癌症发病率的增加、定製药物需求的增加以及测试方法的技术发展是推动市场收入增长的一些主要驱动力。市场参与者正致力于通过采取技术网络开发、合併、研发活动和协作等多种策略来加强其业务。例如，2022 年 6 月，燃石生物科技有限公司宣布，其在美国和中国工厂生产的 OverC (TM) 多种癌症检测血液测试已获得 CE 标誌

最近的发展：

例如，2021年5月，罗氏与GenMark Diagnostics签订合併协议，罗氏将完全收购GenMark。此外，罗氏还计划通过此次收购，利用 GenMark 在综合症检测方面的专业知识来扩大其分子诊断产品组合。

该研究的主要特点：

  • 这项关于肿瘤血液学分子检测市场的研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年。
  • 该报告为客户提供了有关肿瘤血液学分子检测市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了肿瘤血液学分子检测市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、现有参与者面临的挑战以及维持肿瘤血液学分子检测市场的增长因素。
  • 研究范围详细讨论了 COVID-19 对肿瘤血液学分子检测市场规模、预测、复合年增长率和市场动态的影响。还将涵盖对新冠疫情后肿瘤血液学分子检测市场的详细见解。
  • 为了让本报告的用户全面了解肿瘤血液学分子检测市场，我们还对肿瘤血液学分子检测市场的竞争格局和关键创新者进行了分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这些参与者将帮助用户了解在肿瘤血液学分子检测市场中运营的参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球肿瘤血液学分子检测市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和金融分析师。

目录

第 1 章：肿瘤血液学分子检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的肿瘤血液学分子检测市场片段
    • 按癌症类型分類的肿瘤血液学分子检测市场片段
    • 肿瘤血液学分子检测市场技术片段
    • 按最终用途分類的肿瘤血液学分子检测市场片段
    • 按国家/地区分類的肿瘤血液学分子检测市场片段
    • 按地区分類的肿瘤血液学分子检测市场片段
  • 竞争洞察

第 3 章：肿瘤血液学分子检测主要市场趋势

  • 肿瘤血液学分子检测市场驱动因素
    • 市场驱动因素的影响分析
  • 肿瘤血液学分子检测市场限制
    • 市场限制影响分析
  • 肿瘤血液学分子检测市场机会
  • 肿瘤血液学分子检测市场未来趋势

第 4 章：肿瘤血液学分子检测行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：肿瘤血液学分子检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：肿瘤血液学分子检测市场格局

  • 2022 年肿瘤血液学分子检测市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：肿瘤血液学分子检测市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场份额分析
    • 服务
    • 检测试剂盒和试剂

第 8 章：肿瘤血液学分子检测市场 - 按癌症类型

  • 概述
    • 按癌症类型分類的细分市场份额分析
    • 肺癌
    • 血液癌症
    • 乳癌
    • 结直肠癌
    • 其他

第 9 章：肿瘤血液学分子检测市场 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 定量PCR
    • 聚合酶炼式反应
    • 下一代测序
    • 其他的

第 10 章：肿瘤血液学分子检测市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 参考实验室
    • 医院
    • 其他的

第 11 章：肿瘤血液学分子检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 肿瘤血液学分子检测北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按癌症类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲肿瘤血液学分子检测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按癌症类型）
    • 欧洲市场规模和预测（按技术）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区肿瘤血液学分子检测主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按产品类型）
    • 亚太地区市场规模和预测（按癌症类型）
    • 亚太地区市场规模和预测（按技术）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲肿瘤血液学分子检测主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按产品类型）
    • 拉丁美洲市场规模和预测（按癌症类型）
    • 拉丁美洲市场规模和预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 肿瘤血液学分子检测中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按癌症类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析-肿瘤血液学分子检测行业

  • 竞争仪表板
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • DiaSorin Molecular LLC
    • Abbott
    • Thermo Fisher Scientific Inc.
    • Bayer AG
    • GenMark Diagnostics, Inc
    • Biocartis
    • BD
    • Agilent Technologies, Inc
    • QIAGEN
    • HTG Molecular Diagnostics, Inc.
    • Danaher Hologic, Inc.
    • BIOMERIEUX

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1607

REPORT HIGHLIGHT

Onco-hematology molecular testing market size was valued at USD 530.8 Million in 2022, expanding at a CAGR of 13.3% from 2023 to 2030.

Hematology molecular testing is the diagnostic procedure utilized in the field of hematological oncology to monitor and detect blood cancer and related disease. These tests play an essential role in the early diagnosis, treatment, and detection of hematological malignancies including myeloma, leukemia, and lymphoma. Moreover, it also involves numerous technologies such as flow cytometry, molecular testing, next-generation sequencing, and cytogenetics. In addition, these tests assist identify chromosomal abnormalities, genetic mutations, and other molecular markers associated with other types of blood cancers. By examining these makers healthcare professionals can make actual diagnoses, tailor treatment plans, and determine disease progression to individual patients.

Onco-hematology Molecular Testing Market- Market Dynamics:

  • The rising prevalence of cancer cases and new advancements in molecular diagnostics tests may propel the market demand.
  • The demand for diagnosis is driven by the increasing prevalence of cancer cases across the globe, which is fueling up the onco-hematology molecular testing market. Additionally, cancer cases are contributing to the growing requirement for early detection and preventive medicine. As a result, such factors increase the demand steadily for the onco-hematology molecular testing market. Moreover, molecular diagnostics tests for oncology are becoming more popular as diagnostic testing End-use advances. In cancer genome sequencing, tumor models, computational analysis, and innovative cancer research methods, numerous passages are being made. However, in cancer care, the cost of molecular diagnostic testing is comparably higher and it varies depending on the type of therapy which is expected to restrain the market growth over the forecast period.

Onco-hematology Molecular Testing Market- Key Insights:

  • As per the analysis shared by our research analyst, the global onco-hematology molecular testing market is estimated to grow annually at a CAGR of around 13.3% over the forecast period (2023-2030)
  • The onco-hematology molecular testing industry is projected to grow at a significant rate due to the growing number of healthcare infrastructure and well-established healthcare infrastructure
  • Based on technology segmentation, next-generation sequencing was predicted to show maximum market share in the year 2022
  • Based on product type segmentation, services was the leading type in 2022
  • On the basis of region, Asia-Pacific was the leading revenue generator in 2022

Onco-hematology Molecular Testing Market- Segmentation Analysis:

  • The global onco-hematology molecular testing market is segmented on the basis of product type, cancer type, technology, end-use, and region.
  • The market is divided into two categories based on product type: services and assay kits & reagents. The services segment is likely to maintain its dominance over the forecast period owing to its increasing incidence of non-Hodgkin lymphoma, leukemia, and myeloma. Additionally, the segment growth is driven by the increasing awareness regarding several treatment therapies including personalized medicines. The rising availability of services provided for the diagnosis of myeloma is attributed to boosting the growth of the market.
  • The market is divided into four categories based on cancer type: lung cancer, hematological cancer, breast cancer, colorectal cancer, and others. The other cancer segment is accounted to witness the highest growth rate in the market. The rise in the prevalence of various types of cancer such as gastric cancer, prostate cancer, and pancreas cancer globally propel the segment growth.
  • The market is divided into three categories based on technology: qPCR, dPCR, next-generation sequencing, and Others. The next-generation sequencing segment is likely to possess the largest revenue share. The numerous advantages provided by this technology including specificity and more sensitivity are expected to fuel the segment growth. Moreover, next-generation sequencing tests are utilized to examine low levels of cancer cells remaining in patients diagnosed with lymphoblastic leukemia. The FDA approvals for NGS-based tests are attributed to driving the market growth.
  • The market is divided into two categories based on end-use: reference laboratories, hospitals, and others. The hospital segment is expected to dominate the largest revenue share. The rising number of cancer patients' visits for treatment and diagnosis is likely to drive the growth. Moreover, the rise in the incidence rate of blood cancers, the presence of healthcare professionals to conduct diagnostic tests, & monitor the disease, and the availability of specialized laboratory settings is witnessing growth owing to above mention factors.

Onco-hematology Molecular Testing Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Onco-hematology Molecular Testing Market- Competitive Landscape:

Rising healthcare costs and government initiatives aimed at improving cancer treatment and diagnosis are driving market revenue growth. Governments across the world are funding the development of new cancer diagnostic equipment and treatment regimens. Moreover, increasing cancer occurrence, increased need for customized medication, and technical developments in testing methodologies are some of the primary drivers driving market revenue growth. Market players are focusing to strengthen their business by adopting several strategies such as technology network development, mergers, R&D activities, and collaboration. For instance, in June 2022, Burning Rock Biotech Limited introduced that it has received a CE marking for its OverC™ Multi-Cancer Detection Blood Test manufactured in both the US and China facilities

Recent Developments:

For instance, in May 2021, Roche and GenMark Diagnostics entered into a merger agreement in which Roche will fully acquire GenMark. Additionally, Roche aims to expand its portfolio of molecular diagnostics with GenMark's expertise in syndromic testing through the acquisition.

Key features of the study:

  • This proposed research study on onco-hematology molecular testing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the onco-hematology molecular testing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for onco-hematology molecular testing market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the onco-hematology molecular testing market.
  • Impact of COVID-19 on onco-hematology molecular testing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on onco-hematology molecular testing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the onco-hematology molecular testing market, we have also included competitive landscape and key innovator analysis for the onco-hematology molecular testing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the onco-hematology molecular testing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global onco-hematology molecular testing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd
  • DiaSorin Molecular LLC
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Bayer AG
  • GenMark Diagnostics, Inc
  • Biocartis
  • BD
  • Agilent Technologies, Inc
  • QIAGEN
  • HTG Molecular Diagnostics, Inc.
  • Danaher Hologic, Inc.
  • BIOMERIEUX

GLOBALONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY PRODUCT TYPE

  • Services
  • Assay Kits & Reagents

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY CANCER TYPE

  • Lung Cancer
  • Hematological Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Other

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY TECHNOLOGY

  • qPCR
  • dPCR
  • Next-Generation Sequencing
  • Others

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY END-USE

  • Reference Laboratories
  • Hospitals
  • Others

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Onco-hematology Molecular Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Onco-hematology Molecular Testing Market Snippet by Product Type
    • 2.1.2. Onco-hematology Molecular Testing Market Snippet by Cancer Type
    • 2.1.3. Onco-hematology Molecular Testing Market Snippet by Technology
    • 2.1.4. Onco-hematology Molecular Testing Market Snippet by End-use
    • 2.1.5. Onco-hematology Molecular Testing Market Snippet by Country
    • 2.1.6. Onco-hematology Molecular Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Onco-hematology Molecular Testing Key Market Trends

  • 3.1. Onco-hematology Molecular Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Onco-hematology Molecular Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Onco-hematology Molecular Testing Market Opportunities
  • 3.4. Onco-hematology Molecular Testing Market Future Trends

4. Onco-hematology Molecular Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Onco-hematology Molecular Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Onco-hematology Molecular Testing Market Landscape

  • 6.1. Onco-hematology Molecular Testing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Onco-hematology Molecular Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Services
    • 7.1.3. Assay Kits & Reagents

8. Onco-hematology Molecular Testing Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2022&2030 (%)
    • 8.1.2. Lung Cancer
    • 8.1.3. Hematological Cancer
    • 8.1.4. Breast Cancer
    • 8.1.5. Colorectal Cancer
    • 8.1.6. Other

9. Onco-hematology Molecular Testing Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2022&2030 (%)
    • 9.1.2. qPCR
    • 9.1.3. dPCR
    • 9.1.4. Next-Generation Sequencing
    • 9.1.5. Others

10. Onco-hematology Molecular Testing Market - By End-use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
    • 10.1.2. Reference Laboratories
    • 10.1.3. Hospitals
    • 10.1.4. Others

11. Onco-hematology Molecular Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Onco-hematology Molecular Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Onco-hematology Molecular Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Onco-hematology Molecular Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Onco-hematology Molecular Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Onco-hematology Molecular Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Onco-hematology Molecular Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. F. Hoffmann-La Roche Ltd
    • 12.2.2. DiaSorin Molecular LLC
    • 12.2.3. Abbott
    • 12.2.4. Thermo Fisher Scientific Inc.
    • 12.2.5. Bayer AG
    • 12.2.6. GenMark Diagnostics, Inc
    • 12.2.7. Biocartis
    • 12.2.8. BD
    • 12.2.9. Agilent Technologies, Inc
    • 12.2.10. QIAGEN
    • 12.2.11. HTG Molecular Diagnostics, Inc.
    • 12.2.12. Danaher Hologic, Inc.
    • 12.2.13. BIOMERIEUX

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Onco-hematology Molecular Testing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Onco-hematology Molecular Testing Market, by Product Type2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: Cancer TypeSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Type
  • TABLE Global Onco-hematology Molecular Testing Market, by Cancer Type2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Onco-hematology Molecular Testing Market, by Technology 2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: End-use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Onco-hematology Molecular Testing Market, by End-use 2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Onco-hematology Molecular Testing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)